Pathway Therapeutics Ltd.

MyoKardia, a company focused on developing innovative heart disease therapeutics, has appointed Mark Perry to its board of directors. Mr Perry currently serves as chair of the Pathway Therapeutics boa

IN VITRO DIAGNOSTICS Mergers & Acquisitions Institut Merieux bioMerieux SA BioFire Diagnostics Inc. Leading diagnostics firm bioMerieux SA (a division of Institut Merieux ) has agreed to acquir

Asia life science-focused VC firms* *includes non-Asian VCs which have invested in Asian companies; **March 2010 to March 2011 Source: MedTRACK This table accompanies a MedTRACK analysis for the

A new joint Australia/New Zealand fund to support the commercialisation of intellectual property deriving from academic research has made its first investment, in an oncology therapeutics venture. The